Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+45.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.9B
AUM Growth
-$531M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,809
New
Increased
Reduced
Closed

Top Buys

1 +$800M
2 +$304M
3 +$261M
4
LIN icon
Linde
LIN
+$237M
5
JPM icon
JPMorgan Chase
JPM
+$208M

Top Sells

1 +$656M
2 +$632M
3 +$474M
4
PG icon
Procter & Gamble
PG
+$428M
5
MU icon
Micron Technology
MU
+$332M

Sector Composition

1 Technology 22.08%
2 Healthcare 15.35%
3 Industrials 11.11%
4 Consumer Discretionary 10.88%
5 Financials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTB
2776
Connect Biopharma Holdings
CNTB
$137M
$316K ﹤0.01%
120,700
-22,400
THRY icon
2777
Thryv Holdings
THRY
$164M
$315K ﹤0.01%
115,113
-38,087
BOLT icon
2778
Bolt Biotherapeutics
BOLT
$9.8M
$312K ﹤0.01%
77,225
+22,200
NRGV icon
2779
Energy Vault
NRGV
$929M
$312K ﹤0.01%
94,495
-326,305
PAL
2780
Proficient Auto Logistics
PAL
$147M
$311K ﹤0.01%
45,900
-29,900
CRDL
2781
Cardiol Therapeutics
CRDL
$151M
$310K ﹤0.01%
+229,806
JOB icon
2782
GEE Group
JOB
$25.7M
$309K ﹤0.01%
1,288,926
+506,185
VNCE icon
2783
Vince Holding Corp
VNCE
$54.6M
$308K ﹤0.01%
127,812
-9,638
LPCN icon
2784
Lipocine
LPCN
$18.8M
$308K ﹤0.01%
38,497
+1,100
LQDA icon
2785
Liquidia Corp
LQDA
$5.36B
$306K ﹤0.01%
8,100
-198,753
DFIC icon
2786
Dimensional International Core Equity 2 ETF
DFIC
$14.2B
$306K ﹤0.01%
+8,600
RAPP
2787
Rapport Therapeutics
RAPP
$1.91B
$304K ﹤0.01%
9,700
-109,114
TCI icon
2788
Transcontinental Realty Investors
TCI
$344M
$303K ﹤0.01%
8,700
+200
OBIO icon
2789
Orchestra BioMed
OBIO
$237M
$301K ﹤0.01%
70,900
-80,400
THM
2790
International Tower Hill Mines
THM
$644M
$298K ﹤0.01%
+129,595
KNG icon
2791
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.3B
$297K ﹤0.01%
+6,100
NEPH icon
2792
Nephros
NEPH
$38.4M
$296K ﹤0.01%
99,400
-4,372
SOPH icon
2793
SOPHiA GENETICS
SOPH
$358M
$296K ﹤0.01%
59,800
-23,200
ARTW icon
2794
Arts-Way Manufacturing Co
ARTW
$13.9M
$296K ﹤0.01%
141,474
+17,000
HELO icon
2795
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$4.07B
$295K ﹤0.01%
4,621
-7,279
TXMD icon
2796
TherapeuticsMD
TXMD
$24.5M
$295K ﹤0.01%
146,200
+49,700
TVRD
2797
Tvardi Therapeutics
TVRD
$31.6M
$293K ﹤0.01%
92,100
-12,400
WEX icon
2798
WEX
WEX
$5.15B
$291K ﹤0.01%
+1,900
GHRS icon
2799
GH Research
GHRS
$1.58B
$290K ﹤0.01%
+20,614
CNVS icon
2800
Cineverse
CNVS
$52.8M
$288K ﹤0.01%
120,096
-174,851